Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Christina L. Hofmann"'
Autor:
Brendan Huang, Timothy J. McMahon, Christina L. Hofmann, Daniel A. Riccio, Hongmei Zhu, Gregory M. Palmer, Matthew W. Foster
Publikováno v:
Transfusion. 55:2452-2463
BACKGROUND Transfusion of red blood cells (RBCs) is a frequent health care practice. However, unfavorable consequences may occur from transfusions of stored RBCs and are associated with RBC changes during storage. Loss of S-nitrosohemoglobin (SNO-Hb)
Autor:
Douglas H. Weitzel, Christina L. Hofmann, Cassandra L. Fraser, Jelena Samonina-Kosicka, Gregory M. Palmer, Hansford C. Hendargo, Gabi Hanna, Mark W. Dewhirst
Publikováno v:
Macromolecular Rapid Communications. 36:694-699
Surface modification of nanoparticles and biosensors is a dynamic, expanding area of research for targeted delivery in vivo. For more efficient delivery, surfaces are PEGylated to impart stealth properties, long circulation and enable enhanced permea
Autor:
Alexandre Detappe, Chelsea D. Landon, Christina L. Hofmann, Gregory M. Palmer, Wei Qi, Michael J. Therien, Melanie C. O'Sullivan, Yingjie Yu, Xi Yang, P. Peter Ghoroghchian, Mark W. Dewhirst
Motivated by the goal of developing a fully biodegradable optical contrast agent with translational clinical potential, a nanoparticle delivery vehicle was generated from the self-assembly of poly(ethylene-glycol)-block-poly(trimethylene carbonate-co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9376bb9767b9e687e72cb98424e97f9b
https://europepmc.org/articles/PMC5661869/
https://europepmc.org/articles/PMC5661869/
Publikováno v:
American Journal of Physiology-Renal Physiology. 298:F205-F208
The characteristics of the glomerular filtration barrier (GFB) are challenging to measure, as macromolecular solutes in blood may be metabolized or transported by various cells in the kidney. Urinary solute concentrations generally reflect the cumula
Publikováno v:
Blood Purification. 29:259-263
Background: Of 5 clinical trials testing dose response of continuous renal replacement therapy (CRRT) in acute kidney injury, 2 showed a benefit, 2 showed none, and 1 appeared equivocal. However, blood-membrane interactions may dominate macromolecule
Autor:
William H. Fissell, Christina L. Hofmann, Shuvo Roy, Nicholas Ferrell, Peter D. Yurchenco, Lisa Schnell, Andrew L. Zydney, Anna Dubnisheva
Publikováno v:
American Journal of Physiology-Renal Physiology. 297:F1092-F1100
The physiology of glomerular filtration remains mechanistically obscure despite its importance in disease. The correspondence between proteinuria and foot process effacement suggests podocytes as the locus of the filtration barrier. If so, retained m
Autor:
Daniel A, Riccio, Hongmei, Zhu, Matthew W, Foster, Brendan, Huang, Christina L, Hofmann, Gregory M, Palmer, Tim J, McMahon
Publikováno v:
Transfusion. 55(10)
Transfusion of red blood cells (RBCs) is a frequent health care practice. However, unfavorable consequences may occur from transfusions of stored RBCs and are associated with RBC changes during storage. Loss of S-nitrosohemoglobin (SNO-Hb) and other
Publikováno v:
Surgical oncology clinics of North America. 22(3)
There is a need for therapies that can effectively treat primary hepatocellular carcinoma (HCC) as well as metastases to the liver. HCC is the fifth most common cancer worldwide and the fourth most common cause for cancer death.1 Metastasis to the li
Autor:
Nicholas Ferrell, Lingyan Li, Christian A. Zorman, Christina L. Hofmann, William H. Fissell, Joseph J. Groszek, Shuvo Roy, Ross A. Smith
Publikováno v:
American journal of physiology. Renal physiology. 299(4)
The physiology of glomerular permselectivity remains mechanistically obscure, despite its importance in human disease. Although electrical contributions to glomerular permselectivity have long been considered important, two recent reports demonstrate
Autor:
Jelena Samonina-Kosicka, Hsiangkuo Yuan, Tuan Vo-Dinh, Christina L. Hofmann, Gregory M. Palmer, Hansford C. Hendargo, Cassandra L. Fraser, Mark W. Dewhirst, Gabi Hanna
Publikováno v:
Molecular Cancer Therapeutics. 12:B151-B151
Introduction: Advanced biophotonic technology provides a novel strategy to not only achieve target-specific cancer therapy, but also monitor physiological response during treatment. To date, photoactivatable plasmonic nanoparticles (e.g. nanostars; N